Literature DB >> 20876399

A QUICK screen for Lrrk2 interaction partners--leucine-rich repeat kinase 2 is involved in actin cytoskeleton dynamics.

Andrea Meixner1, Karsten Boldt, Marleen Van Troys, Manor Askenazi, Christian J Gloeckner, Matthias Bauer, Jarrod A Marto, Christophe Ampe, Norbert Kinkl, Marius Ueffing.   

Abstract

Mutations in human leucine-rich repeat kinase 2 (Lrrk2), a protein of yet unknown function, are linked to Parkinson's disease caused by degeneration of midbrain dopaminergic neurons. The protein comprises several domains including a GTPase and a kinase domain both affected by several pathogenic mutations. To elucidate the molecular interaction network of endogenous Lrrk2 under stoichiometric constraints, we applied QUICK (quantitative immunoprecipitation combined with knockdown) in NIH3T3 cells. The identified interactome reveals actin isoforms as well as actin-associated proteins involved in actin filament assembly, organization, rearrangement, and maintenance, suggesting that the biological function of Lrrk2 is linked to cytoskeletal dynamics. In fact, we demonstrate Lrrk2 de novo binding to F-actin and its ability to modulate its assembly in vitro. When tested in intact cells, knockdown of Lrrk2 causes morphological alterations in NIH3T3 cells. In developing dopaminergic midbrain primary neurons, Lrrk2 knockdown results in shortened neurite processes, indicating a physiological role of Lrrk2 in cytoskeletal organization and dynamics of dopaminergic neurons. Hence, our results demonstrate that molecular interactions as well as the physiological function of Lrrk2 are closely related to the organization of the actin-based cytoskeleton, a crucial feature of neuronal development and neuron function.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20876399      PMCID: PMC3013447          DOI: 10.1074/mcp.M110.001172

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  78 in total

1.  The familial Parkinsonism gene LRRK2 regulates neurite process morphology.

Authors:  David MacLeod; Julia Dowman; Rachel Hammond; Thomas Leete; Keiichi Inoue; Asa Abeliovich
Journal:  Neuron       Date:  2006-11-22       Impact factor: 17.173

Review 2.  Data merging for integrated microarray and proteomic analysis.

Authors:  Katrina M Waters; Joel G Pounds; Brian D Thrall
Journal:  Brief Funct Genomic Proteomic       Date:  2006-05-10

Review 3.  Enhancing and confirming the specificity of RNAi experiments.

Authors:  Bryan R Cullen
Journal:  Nat Methods       Date:  2006-09       Impact factor: 28.547

4.  Protein interaction screening by quantitative immunoprecipitation combined with knockdown (QUICK).

Authors:  Matthias Selbach; Matthias Mann
Journal:  Nat Methods       Date:  2006-10-29       Impact factor: 28.547

5.  Retraction of synapses and dendritic spines induced by off-target effects of RNA interference.

Authors:  Veronica A Alvarez; Dennis A Ridenour; Bernardo L Sabatini
Journal:  J Neurosci       Date:  2006-07-26       Impact factor: 6.167

6.  Distribution of PINK1 and LRRK2 in rat and mouse brain.

Authors:  Jean-Marc Taymans; Chris Van den Haute; Veerle Baekelandt
Journal:  J Neurochem       Date:  2006-06-12       Impact factor: 5.372

7.  Kinase activity of mutant LRRK2 mediates neuronal toxicity.

Authors:  Wanli W Smith; Zhong Pei; Haibing Jiang; Valina L Dawson; Ted M Dawson; Christopher A Ross
Journal:  Nat Neurosci       Date:  2006-09-17       Impact factor: 24.884

Review 8.  LRRK2: a common pathway for parkinsonism, pathogenesis and prevention?

Authors:  Julie P Taylor; Ignacio F Mata; Matt J Farrer
Journal:  Trends Mol Med       Date:  2006-01-10       Impact factor: 11.951

9.  Localization of LRRK2 to membranous and vesicular structures in mammalian brain.

Authors:  Saskia Biskup; Darren J Moore; Fulvio Celsi; Shinji Higashi; Andrew B West; Shaida A Andrabi; Kaisa Kurkinen; Seong-Woon Yu; Joseph M Savitt; Henry J Waldvogel; Richard L M Faull; Piers C Emson; Reidun Torp; Ole P Ottersen; Ted M Dawson; Valina L Dawson
Journal:  Ann Neurol       Date:  2006-11       Impact factor: 10.422

Review 10.  LRRK2 in Parkinson's disease: protein domains and functional insights.

Authors:  Ignacio F Mata; William J Wedemeyer; Matthew J Farrer; Julie P Taylor; Kathleen A Gallo
Journal:  Trends Neurosci       Date:  2006-04-17       Impact factor: 13.837

View more
  55 in total

1.  The Upshot of LRRK2 Inhibition to Parkinson's Disease Paradigm.

Authors:  A R Esteves; M G-Fernandes; D Santos; C Januário; S M Cardoso
Journal:  Mol Neurobiol       Date:  2014-11-15       Impact factor: 5.590

Review 2.  Early diagnosis and therapy of Parkinson's disease: can disease progression be curbed?

Authors:  Sagar Kansara; Akash Trivedi; Sheng Chen; Joseph Jankovic; Weidong Le
Journal:  J Neural Transm (Vienna)       Date:  2012-06-26       Impact factor: 3.575

3.  LRRK2(I2020T) functional genetic interactors that modify eye degeneration and dopaminergic cell loss in Drosophila.

Authors:  Paul C Marcogliese; Sameera Abuaish; Ghassan Kabbach; Elizabeth Abdel-Messih; Sarah Seang; Gang Li; Ruth S Slack; M Emdadul Haque; Katerina Venderova; David S Park
Journal:  Hum Mol Genet       Date:  2017-04-01       Impact factor: 6.150

Review 4.  A mass spectrometry view of stable and transient protein interactions.

Authors:  Hanna G Budayeva; Ileana M Cristea
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

Review 5.  LRRK2, a puzzling protein: insights into Parkinson's disease pathogenesis.

Authors:  A Raquel Esteves; Russell H Swerdlow; Sandra M Cardoso
Journal:  Exp Neurol       Date:  2014-06-04       Impact factor: 5.330

Review 6.  Proteomics; applications in familial Parkinson's disease.

Authors:  Yan Li; Mark R Cookson
Journal:  J Neurochem       Date:  2019-07-09       Impact factor: 5.372

7.  The G2019S LRRK2 mutation increases myeloid cell chemotactic responses and enhances LRRK2 binding to actin-regulatory proteins.

Authors:  Mark S Moehle; João Paulo Lima Daher; Travis D Hull; Ravindra Boddu; Hisham A Abdelmotilib; James Mobley; George T Kannarkat; Malú G Tansey; Andrew B West
Journal:  Hum Mol Genet       Date:  2015-04-29       Impact factor: 6.150

Review 8.  Genetic analysis of pathways to Parkinson disease.

Authors:  John Hardy
Journal:  Neuron       Date:  2010-10-21       Impact factor: 17.173

Review 9.  Proteomics-based methods for discovery, quantification, and validation of protein-protein interactions.

Authors:  Yana V Miteva; Hanna G Budayeva; Ileana M Cristea
Journal:  Anal Chem       Date:  2012-12-12       Impact factor: 6.986

10.  Regulation of myeloid cell phagocytosis by LRRK2 via WAVE2 complex stabilization is altered in Parkinson's disease.

Authors:  Kwang Soo Kim; Paul C Marcogliese; Jungwoo Yang; Steve M Callaghan; Virginia Resende; Elizabeth Abdel-Messih; Connie Marras; Naomi P Visanji; Jana Huang; Michael G Schlossmacher; Laura Trinkle-Mulcahy; Ruth S Slack; Anthony E Lang; David S Park
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.